{"id":851,"date":"2025-01-22T10:43:35","date_gmt":"2025-01-22T10:43:35","guid":{"rendered":"https:\/\/safetree.in\/blog\/?p=851"},"modified":"2026-02-06T12:34:53","modified_gmt":"2026-02-06T12:34:53","slug":"survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors","status":"publish","type":"post","link":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/","title":{"rendered":"Survey Report &#8211; Impact of the Assisted Reproductive Technology (Regulations) Act 2021 on Oocyte Donors."},"content":{"rendered":"<p><strong>Oocyte (egg) donation<\/strong> in India is a key aspect of <strong>Assisted Reproductive Technologies (ART)<\/strong> and is regulated under the <strong>Assisted Reproductive Technology (Regulation) Act, 2021.<\/strong><\/p>\n<p><!--more--><\/p>\n<p>Oocyte donors play a critical role in helping individuals and couples facing infertility challenges.<\/p>\n<p><a style=\"color: #000000;\" href=\"https:\/\/safetree.in\/\" target=\"_blank\" rel=\"noopener\">SafeTree<\/a>, a leading provider of donor insurance, conducted a survey to evaluate the impact of the <strong>Assisted Reproductive Technology (Regulations) Act 2021<\/strong> on the usage of oocyte donors in India.<\/p>\n<p><span style=\"color: #000000;\">The aim was to gather insights from<strong> IVF specialists<\/strong> and <strong>ART banks<\/strong> with respect to changes in donor availability, client confidence, and the overall process post-implementation of the new regulations.<\/span><\/p>\n<p>The survey reveals a mixed impact of the new ART regulations on the usage of <a href=\"https:\/\/safetree.in\/oocyte\/health-insurance\">oocyte donors<\/a>. The respondents noticed a substantial increase in donor confidence and protection. A few respondents raised some concerns regarding the availability of donors.<\/p>\n<p><span style=\"color: #000000;\">Most IVF specialists are optimistic about the future of donor participation, provided certain regulatory adjustments and process improvements are made. Initiatives to increase awareness in the society regarding the process of oocyte stimulation and retrieval can be explored across the country.<\/span><\/p>\n<p><span style=\"color: #000000;\">We would like to thank all respondents who took part in our survey by sharing valuable insights, and it is our belief that if all stakeholders in the fertility ecosystem work cohesively, there will be increased transparency and accountability, which in effect will be a boon for millions of couples facing fertility challenges in the country.<\/span><\/p>\n<p><span style=\"color: #000000;\">Every donor\u2019s life is precious, and it is our responsibility to provide adequate protection to each donor.<\/span><\/p>\n<p><span style=\"color: #000000;\">The potential for oocyte donors in India is significant due to a combination of demographic and socio-economic factors. The following is an overview of the Oocyte donor market in India &#8211;<\/span><\/p>\n<h2 style=\"font-weight: 600; font-size: 20px; color: black;\">Growing Demand for Oocyte Donation<\/h2>\n<h3 style=\"color: #000000; font-weight: 600; font-size: 16px; margin-top: 30px;\">Infertility rates are on the rise due to<\/h3>\n<ul>\n<li style=\"color: #000000;\">Lifestyle changes, delayed pregnancies, and health conditions have contributed to increased infertility rates in India.<\/li>\n<li style=\"color: #000000;\">According to estimates, around 15% &#8211; 20% of couples in India face infertility issues, fuelling demand for advanced fertility solutions like egg donation.<\/li>\n<li style=\"color: #000000;\">The gross fertility rate in India has decreased by almost 20% in the last decade in India.<\/li>\n<li style=\"color: #000000;\">The human sperm count has fallen by over 50% over the last 50 years, as per a study published in the Human Reproductive Update journal.<\/li>\n<\/ul>\n<h3 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Boom in Assisted Reproductive Technology (ART)<\/h3>\n<ul>\n<li style=\"color: #000000;\">India has a thriving fertility industry, with over 2,000 ART clinics.<\/li>\n<li style=\"color: #000000;\">The rising use of <a href=\"https:\/\/safetree.in\/parenthood\">in vitro fertilisation (IVF)<\/a> has expanded the need for donor eggs, particularly for women with poor egg quality or early ovarian failure.<\/li>\n<\/ul>\n<h2 style=\"font-weight: 600; font-size: 20px; color: black;\">Large, Diverse Population Pool for Oocyte Donors<\/h2>\n<ul>\n<li style=\"color: #000000; margin-top: 30px;\"><span style=\"font-weight: 600;\">Young Population \u2013 India<\/span>\u00a0has a vast pool of women in the reproductive age group (23y-35y), which aligns with the eligibility criteria for egg donation.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Diverse Genetic Profiles \u2013 India\u2019s<\/span>\u00a0diversity in ethnic and genetic backgrounds is a unique advantage for couples seeking donors that match specific characteristics.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Awareness and Education \u2013<\/span>\u00a0Education initiatives within society to increase awareness regarding the process of oocyte stimulation and retrieval can be explored.<\/li>\n<\/ul>\n<h2 style=\"font-weight: 600; font-size: 20px; color: black;\">Awareness Gaps and Addressable Market<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Low Awareness Levels \u2013 Many<\/span>\u00a0women remain unaware of the opportunity to become egg donors or the medical safety measures involved.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Addressable Market \u2013<\/span>\u00a0Raising awareness among urban and semi-urban populations could unlock a substantial potential donor base.<\/li>\n<\/ul>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Policy and Ethical Safeguards<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Regulated Industry &#8211;<\/span> The ART Regulation Act, 2021, ensures ethical practices and protects the health and rights of donors, making the process safer and more transparent.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Insurance Opportunities \u2013 Oocyte<\/span> donor insurance has enhanced confidence among donors, assuring them of financial and medical coverage.<\/li>\n<\/ul>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Challenges to Overcome<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Social Stigma \u2013 Cultural<\/span>\u00a0and societal perceptions about fertility and reproduction can deter some women from participating.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Medical Concerns \u2013<\/span>\u00a0Ensuring proper care and minimising risks like Ovarian Hyperstimulation Syndrome (OHSS) is critical to encouraging donor participation.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Accessibility \u2013<\/span> Clinics and organisations need to make egg donation accessible in Tier 2 and Tier 3 cities, where awareness and penetration remain low.<\/li>\n<\/ul>\n<h3 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Market Potential<\/h3>\n<p>It is estimated that India has 300-500 lakh couples with fertility challenges and 2-3 lakh IVF cycles conducted annually. Given the rising infertility rates and growing ART adoption, the market for oocyte donors is expected to grow substantially.<\/p>\n<p>The following are key findings of the survey conducted to understand the impact of the <strong>Assisted Reproductive Technology (Regulations) Act 2021<\/strong> on the usage of <strong>Oocyte donors<\/strong> in India &#8211;<\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Client Confidence<\/h2>\n<p><strong>Increased Confidence \u2013<\/strong>\u00a0A significant majority (57%) of respondents indicated that client confidence in the system has increased post-implementation of the new ART regulations.<\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Donor Availability<\/h2>\n<p><strong>Decreased Availability \u2013<\/strong> Many respondents noted that donor availability has gone down since the implementation of new regulations.<\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Donor Protection<\/h2>\n<p><strong>Better Protection \u2013<\/strong> A common piece of positive feedback was that donors now have better protection due to the new regulations.<\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 18px;\">Usage of Oocyte Donors<\/h2>\n<p><strong>Mixed Experiences &#8211;\u00a0<\/strong><\/p>\n<ul>\n<li style=\"color: #000000;\">37% of respondents reported a decrease in the usage of oocyte donors.<\/li>\n<li style=\"color: #000000;\">The remaining 63% reported an increase or no significant change in usage of oocyte donors.<\/li>\n<\/ul>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Future Donor Participation<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Will Increase \u2013<\/span>\u00a0The majority (66%) of respondents believe that oocyte donor participation will increase in the coming times.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Will Decrease \u2013<\/span> A smaller percentage (29%) of respondents believe oocyte donor participation will decrease.<\/li>\n<\/ul>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Insurance Coverage<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Health and Life Insurance \u2013<\/span> Over 60% of respondents ensure both <a style=\"color: #000000;\" href=\"https:\/\/safetree.in\/surrogate\/health-insurance\" target=\"_blank\" rel=\"noopener\">health<\/a> and <a style=\"color: #000000;\" href=\"https:\/\/safetree.in\/surrogate\/life-insurance\" target=\"_blank\" rel=\"noopener\">life insurance<\/a> for their oocyte donors.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Health Insurance Only &#8211; <\/span>A few specialists provide only health insurance.<\/li>\n<\/ul>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 20px;\">Sourcing of Oocyte Donors<\/h2>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">ART Banks &#8211;<\/span>\u00a0The majority source their oocyte donors from ART banks.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Direct Sourcing \u2013<\/span>\u00a0Some specialists source donors directly.<\/li>\n<\/ul>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone wp-image-861\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte_Donor_Survey-e1737536555296-1024x923.jpg\" alt=\"\" width=\"800\" height=\"721\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte_Donor_Survey-e1737536555296-1024x923.jpg 1024w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte_Donor_Survey-e1737536555296-300x270.jpg 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte_Donor_Survey-e1737536555296-768x692.jpg 768w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte_Donor_Survey-e1737536555296.jpg 1292w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Survey Recommendations<\/h2>\n<div>\n<ul>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Enhance Donor Availability \u2013<\/span>\u00a0Explore opportunities to increase donor availability.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Implement Verification Tools \u2013<\/span>\u00a0Develop tools for verifying donor identity to prevent multiple donations.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Regulatory Adjustments \u2013<\/span>\u00a0To review the current regulatory framework to ensure a balance between donor protection and availability.<\/li>\n<li style=\"color: #000000;\"><span style=\"font-weight: 600;\">Mandatory Insurance for Donors \u2013<\/span> To ensure compliance of health and life insurance for oocyte donors, awareness sessions should be conducted.<\/li>\n<\/ul>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone wp-image-870\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance-1024x683.jpg\" alt=\"\" width=\"800\" height=\"533\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance-1024x683.jpg 1024w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance-300x200.jpg 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance-768x512.jpg 768w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance-1536x1024.jpg 1536w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-_insurance.jpg 1728w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>What percentage of couples consider an Oocyte Donor<\/p>\n<div>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-871\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question1-300x167.png\" alt=\"\" width=\"450\" height=\"250\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question1-300x167.png 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question1-768x426.png 768w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question1.png 922w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>As per 50% of the respondents, nearly 1 in 5 couples consider an Oocyte donor<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<div style=\"float: left; width: 100%; margin-top: 40px;\">\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>What has been your experience regarding utilization of Oocyte Donors post ART regulations<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-874\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-1.png\" alt=\"\" width=\"450\" height=\"207\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-1.png 918w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-1-300x138.png 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-1-768x353.png 768w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>Nearly 40% of the respondents have experienced an increase in Oocyte donors post implementation of ART regulations. This is expected given the drop in fertility rates.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<div style=\"float: left; width: 100%; margin-top: 40px;\">\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>I believe Oocyte Donor participation in coming times will<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-875\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question3.png\" alt=\"\" width=\"450\" height=\"199\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question3.png 924w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question3-300x132.png 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question3-768x339.png 768w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>Nearly 2\/3 of the respondents believe there will be increased participation of Oocyte donors in the years to come.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<div style=\"float: left; width: 100%; margin-top: 40px;\">\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>We ensure following insurance cover for our Oocyte Donors<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-876 size-full\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question4-e1737541413799.png\" alt=\"\" width=\"450\" height=\"238\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question4-e1737541413799.png 450w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question4-e1737541413799-300x159.png 300w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>Regulations require that Ooctye donors to have Health and Life insurance coverage.<\/p>\n<p>However, 40% of donors are not provided with life insurance. Need to increase awareness regarding compliance requirements.<\/p>\n<\/div>\n<div style=\"float: left; width: 100%; margin-top: 40px;\">\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>We source Oocyte Donors from<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-873\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2.png\" alt=\"\" width=\"450\" height=\"190\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2.png 932w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-300x127.png 300w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question2-768x325.png 768w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>86% of respondents rely on ART Banks for Oocyte donors.<\/p>\n<\/div>\n<div style=\"float: left; width: 100%; margin-top: 40px;\">\n<p>&nbsp;<\/p>\n<p style=\"text-decoration: underline;\"><b>Q &#8211; <\/b>From your perspective what is your assessment post implementation of new ART regulations (Multiple options selected)<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-877 size-full\" src=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question6-e1737541676878.png\" alt=\"\" width=\"450\" height=\"213\" srcset=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question6-e1737541676878.png 450w, https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/question6-e1737541676878-300x142.png 300w\" sizes=\"(max-width: 450px) 100vw, 450px\" \/><\/p>\n<h2 style=\"color: #000000; font-weight: 600; font-size: 16px;\">Key Takeaways<\/h2>\n<p>2\/3 for respondents believe Oocyte donors have better insurance protection now.<\/p>\n<p>57% have increased confidence in the system post new guidelines.<\/p>\n<p>50% respondents have experienced a drop in donor availability.<\/p>\n<\/div>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oocyte (egg) donation in India is a key aspect of Assisted Reproductive Technologies (ART) and is regulated under the Assisted Reproductive Technology (Regulation) Act, 2021.<\/p>\n","protected":false},"author":1,"featured_media":853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[118],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree<\/title>\n<meta name=\"description\" content=\"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree\" \/>\n<meta property=\"og:description\" content=\"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/\" \/>\n<meta property=\"og:site_name\" content=\"SafeTree\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-22T10:43:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T12:34:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-Donor-Survey.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2477\" \/>\n\t<meta property=\"og:image:height\" content=\"1652\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Safetree\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Safetree\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/\",\"url\":\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/\",\"name\":\"Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree\",\"isPartOf\":{\"@id\":\"https:\/\/safetree.in\/blog\/#website\"},\"datePublished\":\"2025-01-22T10:43:35+00:00\",\"dateModified\":\"2026-02-06T12:34:53+00:00\",\"author\":{\"@id\":\"https:\/\/safetree.in\/blog\/#\/schema\/person\/0340f0a95a7d2e032528a56f09815aa5\"},\"description\":\"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.\",\"breadcrumb\":{\"@id\":\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/safetree.in\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survey Report &#8211; Impact of the Assisted Reproductive Technology (Regulations) Act 2021 on Oocyte Donors.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/safetree.in\/blog\/#website\",\"url\":\"https:\/\/safetree.in\/blog\/\",\"name\":\"Safetree\",\"description\":\"Corporate Insurance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/safetree.in\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/safetree.in\/blog\/#\/schema\/person\/0340f0a95a7d2e032528a56f09815aa5\",\"name\":\"Safetree\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/safetree.in\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9a75b59c6c1e17307783e425ae9ae0db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9a75b59c6c1e17307783e425ae9ae0db?s=96&d=mm&r=g\",\"caption\":\"Safetree\"},\"sameAs\":[\"https:\/\/safetree.in\/blog\",\"https:\/\/www.linkedin.com\/company\/safetreeprotection\/\"],\"url\":\"https:\/\/safetree.in\/blog\/author\/safetree\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree","description":"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/","og_locale":"en_US","og_type":"article","og_title":"Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree","og_description":"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.","og_url":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/","og_site_name":"SafeTree","article_published_time":"2025-01-22T10:43:35+00:00","article_modified_time":"2026-02-06T12:34:53+00:00","og_image":[{"width":2477,"height":1652,"url":"https:\/\/safetree.in\/blog\/wp-content\/uploads\/2025\/01\/SafeTree_Oocyte-Donor-Survey.jpg","type":"image\/jpeg"}],"author":"Safetree","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Safetree","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/","url":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/","name":"Impact of ART (Regulations) Act 2021 on Oocyte Donors | SafeTree","isPartOf":{"@id":"https:\/\/safetree.in\/blog\/#website"},"datePublished":"2025-01-22T10:43:35+00:00","dateModified":"2026-02-06T12:34:53+00:00","author":{"@id":"https:\/\/safetree.in\/blog\/#\/schema\/person\/0340f0a95a7d2e032528a56f09815aa5"},"description":"Explore the impact of the Assisted Reproductive Technology (ART) Act 2021 on oocyte donors in India. Read our survey report for key insights and findings.","breadcrumb":{"@id":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/safetree.in\/blog\/survey-report-impact-of-the-assisted-reproductive-technology-regulations-act-2021-on-oocyte-donors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/safetree.in\/blog\/"},{"@type":"ListItem","position":2,"name":"Survey Report &#8211; Impact of the Assisted Reproductive Technology (Regulations) Act 2021 on Oocyte Donors."}]},{"@type":"WebSite","@id":"https:\/\/safetree.in\/blog\/#website","url":"https:\/\/safetree.in\/blog\/","name":"Safetree","description":"Corporate Insurance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/safetree.in\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/safetree.in\/blog\/#\/schema\/person\/0340f0a95a7d2e032528a56f09815aa5","name":"Safetree","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/safetree.in\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9a75b59c6c1e17307783e425ae9ae0db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9a75b59c6c1e17307783e425ae9ae0db?s=96&d=mm&r=g","caption":"Safetree"},"sameAs":["https:\/\/safetree.in\/blog","https:\/\/www.linkedin.com\/company\/safetreeprotection\/"],"url":"https:\/\/safetree.in\/blog\/author\/safetree\/"}]}},"_links":{"self":[{"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/posts\/851"}],"collection":[{"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/comments?post=851"}],"version-history":[{"count":60,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/posts\/851\/revisions"}],"predecessor-version":[{"id":1484,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/posts\/851\/revisions\/1484"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/media\/853"}],"wp:attachment":[{"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/media?parent=851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/categories?post=851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/safetree.in\/blog\/wp-json\/wp\/v2\/tags?post=851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}